Change in tumor microenvironment and PD-L1 expression with rucaparib treatment in triple-negative breast cancer.

被引：0
|
作者：
Halder, Ritika
Bhamidipati, Nitish
Kiss, Alexi
Aldhahri, Walaa
Ehsani, Sima
Segar, Jennifer Margaret
Foster, Nova
Chalasani, Pavani
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] George Washington Univ, Washington, DC USA
[3] George Washington Univ Hosp, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    [J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [2] Transcription factor T-bet and PD-L1 expression in tumor microenvironment of triple-negative breast cancer
    Mori, H.
    Kubo, M.
    Kai, M.
    Kurata, K.
    Kawaji, H.
    Kaneshiro, K.
    Motoyama, Y.
    Kuroki, R.
    Yamada, M.
    Nishimura, R.
    Okido, M.
    Oda, Y.
    Nakamura, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [3] Effect of PD-1 and PD-L1 in the tumor microenvironment on overall survival of triple-negative breast cancer patients
    Linnaus, M. E.
    Kosiorek, H.
    Barrett, M. T.
    Dueck, A.
    Anderson, K. S.
    Ocal, I. T.
    McCullough, A. E.
    Annamalai, L.
    Yearley, J. H.
    Pockaj, B. A.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Ben Dori, Shani
    Aizic, Asaf
    Zubkov, Asia
    Tsuriel, Shlomo
    Sabo, Edmond
    Hershkovitz, Dov
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 297 - 305
  • [5] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Shani Ben Dori
    Asaf Aizic
    Asia Zubkov
    Shlomo Tsuriel
    Edmond Sabo
    Dov Hershkovitz
    [J]. Breast Cancer Research and Treatment, 2022, 194 : 297 - 305
  • [6] PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
    Wang Xinran
    Liu, Yueping
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [7] Role of PD-L1 expression in triple-negative breast cancer stem cells
    Di Nicola, Massimo A.
    Castagnoli, Lorenzo
    Cancila, Valeria
    Romero, Sandra
    Faraci, Simona
    Chiodoni, Claudia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Clinicopathological significance of PD-L1 expression in patients with triple-negative breast cancer
    Basheska, N.
    Ognenoska-Jankovska, B.
    [J]. HISTOPATHOLOGY, 2022, 81 : 26 - 27
  • [9] The effect of cardamonin on PD-L1 expression in triple-negative breast cancer cells
    Mendonca, Patricia
    Kirpal, Bhonessa
    Kaur, Sukhmandeep
    Soliman, Karam F. A.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [10] PD1, PD-L1 and PD-L2 mRNA Expression in triple-negative Breast Cancer
    Schueler, K.
    Bethmann, D.
    Staege, M.
    Kantelhardt, J. E.
    Thomssen, C.
    Vetter, M.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : E24 - E24
12345